iShares Biotechnology ETF
IBBNASDAQBlackRockEquity
As of Oct 15, 2026 close
- Assets (AUM)
- $10.64B
- Expense ratio
- 0.44%
- Dividend yield
- 0.16%
- Holdings
- 248
- 52-week range
- $151.01$217.12
- Volume (live)
- -
- Avg. volume (3M)
- 1.64M
IBB ETF: iShares Biotechnology ETF - Price, Holdings & Analysis
iShares Biotechnology ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $204.54 - $208.96 |
|---|---|
| 52-Week High | $217.12 |
| 52-Week Low | $151.01 |
| Open | $205.48 |
| Volume (last close) | 1.84M |
| Average Volume (3M) | 1.64M |
| 1 Day Change | +2.05% |
|---|---|
| 1 Month Change | +2.48% |
| 6 Month Change | +19.12% |
| YTD Change | +22.73% |
| 1 Year Change | +35.19% |
| 5 Year Change | +32.06% |
| 10 Year Change | +133.85% |
| Annual Dividend | $0.34 |
|---|---|
| Dividend Yield | 0.16% |
| Last Dividend Ex-Date | Sep 15, 2026 |
| Dividend Growth YoY | +27.59% |
| Assets (AUM) | $10.64B |
|---|---|
| Expense Ratio | 0.44% |
| Total Holdings | 248 |
| Inception Date | Feb 4, 2001 |
| 50-Day MA | $206.19 |
|---|---|
| 200-Day MA | $182.39 |
| RSI | 47.06 |
| Stochastic %K | 40.51 |
| Stochastic %D | 35.81 |
Source: Exchange price data and fund disclosures. Data as of Oct 15, 2026. Data sources and methodology
IBB at a Glance
iShares Biotechnology ETF (IBB) is an equity ETF from BlackRock, launched in February 2001. It manages $10.64B in assets and charges a 0.44% expense ratio, about $44 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 248 positions. The largest are Gilead Sciences, Inc (GILD, 8.26%), Amgen Inc. (AMGN, 7.63%) and Vertex Pharmaceuticals Incorporated (VRTX, 7.54%). The top 10 holdings make up 49.9% of the fund. By sector it leans toward Healthcare (100.0%). 94.0% of assets are in the United States.
It pays distributions yielding 0.16% at the Oct 15, 2026 close, $0.34 per share over the trailing 12 months. As of the Oct 15, 2026 close, the share price is up 35.2% over one year, up 32.1% over five years and up 133.9% over ten years (price change, excluding distributions).
Frequently Asked Questions About iShares Biotechnology ETF
What is the current price of IBB?
The latest IBB price is $207.41 (Oct 15, 2026 close). The 52-week range is $151.01–$217.12. The share price is up 35.2% over the past year (price change, excluding distributions).
What is the expense ratio for IBB?
IBB's annual expense ratio is 0.44%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does IBB pay dividends?
Yes, IBB pays a 0.16% dividend yield (trailing 12 months, at the Oct 15, 2026 close). The most recent ex-dividend date was September 15, 2026. View full dividend history in the Dividends section.
What are the top holdings of IBB?
As of Oct 4, 2026, IBB's largest holdings are Gilead Sciences, Inc (8.3%), Amgen Inc. (7.6%), Vertex Pharmaceuticals Incorporated (7.5%) (combined weight: 23.4%). The fund holds 248 total positions. View the complete portfolio breakdown in the Holdings section.
How does IBB compare to similar ETFs?
Compare IBB (0.44% expense ratio, $10.64B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.